Skip to main content

Advertisement

SpringerLink
Log in

Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), october 18–19, 2012, Belo Horizonte, Minas Gerais, Brazil

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

To discuss and share knowledge about advances in the care of patients with thrombotic disorders, the Fifth International Symposium of Thrombosis and Anticoagulation was held in Belo Horizonte, Minas Gerais, Brazil, on October 18–19, 2012. This scientific program was developed by clinicians for clinicians and was promoted by three major clinical research institutes: the Brazilian Clinical Research Institute, the Duke Clinical Research Institute of the Duke University School of Medicine, and Hospital do Coração Research Institute. Comprising 2 days of academic presentations and open discussion, the symposium had as its primary goal to educate, motivate, and inspire internists, cardiologists, hematologists, and other physicians by convening national and international visionaries, thought-leaders, and dedicated clinician-scientists. This paper summarizes the symposium proceedings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Recommended Reading

  1. ACTIVE Writing Group (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomized controlled trial. Lancet 367:1903–1912

    Article  Google Scholar 

  2. Adams HP Jr, del Zoppo G, Alberts MJ et al (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association. Stroke 38:1655–1711

    Article  PubMed  Google Scholar 

  3. Ainsworth CD, Blake CC, Tamayo A et al (2005) 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke 36:1904–1909

    Article  PubMed  Google Scholar 

  4. Alexander KP, Chen AY, Roe MT et al (2005) Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 294:3108–3116

    Article  PubMed  CAS  Google Scholar 

  5. Alexander KP, Peterson ED (2010) Minimizing the risks of anticoagulants and platelet inhibitors. Circulation 121:1960–1970

    Article  PubMed  Google Scholar 

  6. Anderson JL, Adams CD, Antman EM et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 50:e1–e157

    Article  PubMed  Google Scholar 

  7. Avgil Tsadok M (2012) Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 307:1952–1958

    Article  PubMed  Google Scholar 

  8. Bailey AL, Scantlebury DC, Smyth SS (2009) Thrombosis and antithrombotic therapy in women. Arterioscler Thromb Vasc Biol 29:284–288

    Article  PubMed  CAS  Google Scholar 

  9. Barbar S, Noventa F, Rossetto V et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8:2450–2457

    Article  PubMed  CAS  Google Scholar 

  10. Berwanger O, Guimarães HP, Laranjeira LN et al (2012) Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial. JAMA 307:2041–2049

    Article  PubMed  CAS  Google Scholar 

  11. Boersma E, Harrington RA, Moliterno DJ et al (2002) Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 359:189–198

    Article  PubMed  CAS  Google Scholar 

  12. Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118:e523–e661

    Article  PubMed  Google Scholar 

  13. Brennan JM, Edwards FH, Zhao Y et al (2012) Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. J Am Coll Cardiol 60:971–977

    Article  PubMed  Google Scholar 

  14. Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 23:2369–2429

    Google Scholar 

  15. Capodanno D, Angiolillo DJ (2010) Impact of race and gender on antithrombotic therapy. Thromb Haemost 104:471–484

    Article  PubMed  CAS  Google Scholar 

  16. Chan MY, Sun JL, Wang TY et al (2010) Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: a pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY. Am Heart J 160:1056–1064

    Article  PubMed  Google Scholar 

  17. Cohen M, Demers C, Gurfinkel EP et al (1997) A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 337:447–452

    Article  PubMed  CAS  Google Scholar 

  18. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429–1435

    Article  Google Scholar 

  19. Cooper HA, Rao SV, Greenberg MD et al (2011) Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol 108:1108–1111

    Article  PubMed  Google Scholar 

  20. Costa GL, Ferreira DC, Valacio RA, Vieira Moreira Mda C (2011) Quality of management of oral anticoagulation as assessed by time in therapeutic INR range in elderly and younger patients with low mean years of formal education: a prospective cohort study. Age Ageing 40:375–381

    Article  PubMed  Google Scholar 

  21. Ducharme A, Swedberg K, Pfeffer MA et al (2006) Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J 151:985–991

    Article  PubMed  Google Scholar 

  22. Eikelboom JW, Wallentin L, Connolly SJ et al (2011) Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation. Circulation 123:2363–2372

    Article  PubMed  CAS  Google Scholar 

  23. Ensor CR, Cahoon WD, Crouch MA et al (2010) Antithrombotic therapy for the CardioWest temporary total artificial heart. Texas Heart Inst J 37:149–158

    Google Scholar 

  24. Ezekowitz MD, Wallentin L, Connolly SJ et al (2010) Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation. Circulation 122:2246–2253

    Article  PubMed  CAS  Google Scholar 

  25. Feinstein SB (2006) Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol 48:236–243

    Article  PubMed  Google Scholar 

  26. Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators, Yusuf S, Mehta SR et al (2006) Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 354:1464–1476

    Article  PubMed  CAS  Google Scholar 

  27. Fox KAA, Piccini JP, Wojdyla D et al (2011) Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J 32:2387–2394

    Article  PubMed  CAS  Google Scholar 

  28. Furie KL, Goldistein LB, Albers GW et al (2012) Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 43:3442–3453

    Article  PubMed  Google Scholar 

  29. Furie KL, Kasner SE, Adams RJ et al (2011) Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:227–276

    Article  PubMed  Google Scholar 

  30. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870

    Article  PubMed  CAS  Google Scholar 

  31. Goldhaber SZ, Leizorovicz A, Kakkar AK et al (2011) Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 365:2167–2177

    Article  PubMed  CAS  Google Scholar 

  32. Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992

    Article  PubMed  CAS  Google Scholar 

  33. Gualandro DM, Yu PC, Calderaro D et al (2011) II guidelines for perioperative evaluation. Arq Bras Cardiol 96(3 Suppl 1):1

    PubMed  Google Scholar 

  34. Healey JS, Connolly SJ, Gold MR et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366:120–129

    Article  PubMed  CAS  Google Scholar 

  35. Hijazi Z, Oldgren J, Andersson U et al (2012) Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation 125:1605–1616

    Article  PubMed  CAS  Google Scholar 

  36. Hohnloser SH, Hijazi Z, Thomas L et al (2012) Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J 33:2821–2830

    Article  PubMed  CAS  Google Scholar 

  37. Homma S, Thompson JL, Pullicino PM et al (2012) Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 366:1859–1869

    Article  PubMed  CAS  Google Scholar 

  38. Khan IA (2003) Atrial stunning: basics and clinical consideration. Int J Cardiol 2003(92):113–128

    Article  Google Scholar 

  39. Klein AL, Grimm RA, Murray RD et al (2001) Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 344:1411–1420

    Article  PubMed  CAS  Google Scholar 

  40. Lazar RM, Shapiro PA, Jaski BE et al (2004) Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation 109:2423–2427

    Article  PubMed  Google Scholar 

  41. Leiria TL, Pellanda L, Miglioranza MH et al (2010) Warfarin and phenprocoumon: experience of an outpatient anticoagulation clinic. Arq Bras Cardiol 94:40–43

    Article  CAS  Google Scholar 

  42. Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607

    Article  PubMed  CAS  Google Scholar 

  43. Lindqvist PG, Epstein E, Olsson H (2008) The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study. Br J Haematol 144:234–240

    Article  PubMed  Google Scholar 

  44. Lip GYH, Ponikowski P, Andreotti F et al (2012) Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Eur J Heart Fail 14:681–695

    Article  PubMed  CAS  Google Scholar 

  45. Little SH, Massel DR (2003) Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev 4:CD003464

    Google Scholar 

  46. Lopes RD, Peterson ED, Chen AY et al (2010) Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. J Am Coll Cardiol Intv 3:669–677

    Google Scholar 

  47. Lopes RD, Subherwal S, Holmes DN et al (2012) The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. Eur Heart J 33:2044–2053

    Article  PubMed  Google Scholar 

  48. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness—a systematic review and meta-analysis. Circulation 115:459–467

    Article  PubMed  Google Scholar 

  49. Lorenz MW, Polak JF, Kavousi M et al (2012) Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 379:2053–2062

    Article  PubMed  Google Scholar 

  50. Lubenow N, Hinz P, Thomaschewski S et al (2010) The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia. Blood 115:1797–1803

    Article  PubMed  CAS  Google Scholar 

  51. Maggioni A, Latini R, Carson PE et al (2005) Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J 149:548–557

    Article  PubMed  CAS  Google Scholar 

  52. Mehran R, Pocock SJ, Nikolsky E et al (2010) A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol 55:2556–2566

    Article  PubMed  Google Scholar 

  53. Mehran R, Pocock SJ, Stone GW et al (2009) Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J 30:1457–1466

    Article  PubMed  Google Scholar 

  54. Mehran R, Rao SV, Bhatt DL et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736–2747

    Article  PubMed  Google Scholar 

  55. Mehta SK, Frutkin AD, Lindsey JB et al (2009) Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Intv 2:222–229

    Article  Google Scholar 

  56. Miedema I, Luijckx GJ, De Keyser J, Koch M, Uyttenboogaart M (2012) Thrombolytic therapy for ischaemic stroke in patients using warfarin: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 83:537–540

    Article  PubMed  Google Scholar 

  57. Morrow DA, Braunwald E, Bonaca MP et al (2012) Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med 366:1404–1413

    Article  PubMed  CAS  Google Scholar 

  58. Mountantonakis SE, Grau-Sepulveda MV, Bhatt DL, Hernandez AF, Peterson ED, Fonarow GC (2012) Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of Get With The Guidelines-Heart Failure. Circ Heart Fail 5:191–201

    Article  PubMed  Google Scholar 

  59. Olesen J, Lip GY, Hansen ML et al (2011) Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 342:d124

    Article  PubMed  Google Scholar 

  60. Olsson SG, Swedberg K, Ducharme A et al (2006) Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 47:1997–2004

    Article  PubMed  Google Scholar 

  61. Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891

    Article  PubMed  CAS  Google Scholar 

  62. Petersen JL, Mahaffey KW, Hasselblad V et al (2004) Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: a systematic overview. JAMA 29289–29296

  63. Potapov EV, Krabatsch T, Ventura HO, Hetzer R (2011) Advances in mechanical circulatory support: year in review. J Heart Lung Transplant 30:487–493

    Article  PubMed  Google Scholar 

  64. Price J, Hynes M, Labinaz M, Ruel M, Boodhwani M (2012) Mechanical valve thrombosis with dabigatran. J Am Coll Cardiol 60:1710–1711

    Article  PubMed  Google Scholar 

  65. The PURSUIT Trial Investigators (1998) Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 339:436–443

    Article  Google Scholar 

  66. Rao SV, Eikelboom J, Steg PG et al (2009) Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group. Am Heart J 158(881–886):e1

    PubMed  Google Scholar 

  67. Rao SV, Jollis JG, Harrington RA et al (2004) Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292:1555–1562

    Article  PubMed  CAS  Google Scholar 

  68. Rao SV, Kaul PR, Liao L et al (2008) Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 155:369–374

    Article  PubMed  Google Scholar 

  69. Rao SV, O’Grady K, Pieper KS et al (2005) Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 96:1200–1206

    Article  PubMed  Google Scholar 

  70. Rao SV, O’Grady K, Pieper KS et al (2006) A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 47:809–816

    Article  PubMed  Google Scholar 

  71. Rossi M, Serraino GF, Jiritano F, Renzulli A (2012) What is the optimal anticoagulation in patients with a left ventricular assist device? Interact Cardiovasc Thorac Surg 15:733–740

    Article  PubMed  Google Scholar 

  72. Roy D, Talajic M, Nattel S et al (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677

    Article  PubMed  CAS  Google Scholar 

  73. Roy P, Bonello L, Torguson R et al (2008) Impact of “nuisance” bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol 102:1614–1617

    Article  PubMed  Google Scholar 

  74. Scirica BM, Bonaca MP, Braunwald E et al (2012) Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial. Lancet 380:1317–1324

    Article  PubMed  CAS  Google Scholar 

  75. Shantsila E, Lip GY, Chong BH (2009) Heparin-induced thrombocytopenia: a contemporary clinical approach to diagnosis and management. Chest 135:1651–1664

    Article  PubMed  CAS  Google Scholar 

  76. Shibazaki K, Kimura K, Fujii S, Sakai K, Iguchi Y (2012) Brain natriuretic peptide levels as a predictor for new atrial fibrillation during hospitalization in patients with acute ischemic stroke. Am J Cardiol 109:1303–1307

    Article  PubMed  CAS  Google Scholar 

  77. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685–691

    Article  Google Scholar 

  78. Spyropoulos AC, Anderson FA Jr, Fitzgerald G et al (2011) Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140:706–714

    Article  PubMed  Google Scholar 

  79. Stein JH, Korcarz CE, Hurst RT et al (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 21:93–111

    Article  PubMed  Google Scholar 

  80. Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 108:978–981

    Article  PubMed  CAS  Google Scholar 

  81. Subherwal S, Bach RG, Chen AY et al (2009) Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 119:1873–1882

    Article  PubMed  Google Scholar 

  82. Suissa L, Bresch S, Lachaud S, Mahagne MH (2012) Brain natriuretic peptide: a relevant marker to rule out delayed atrial fibrillation in stroke patient. J Stroke Cerebrovasc Dis. doi:10.1016/j.jstrokecerebrovasdis.2012.08.010

    Google Scholar 

  83. Sun JC, Davidson MJ, Lamy A, Eikelboom JW (2009) Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet 374:565–576

    Article  PubMed  Google Scholar 

  84. Swedberg K, Zannad F, McMurray JJ et al (2012) Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. J Am Coll Cardiol 59:1598–1603

    Article  PubMed  CAS  Google Scholar 

  85. Taylor D, Stehlik J, Edwards LB et al (2009) Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report: 2009. J Heart Lung Transplant 28:1007–1022

    Article  PubMed  Google Scholar 

  86. Tricoci P, Peterson ED, Mulgund J et al (2006) Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE). Am J Cardiol 98:1172–1176

    Article  PubMed  Google Scholar 

  87. Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 28:230–268

    PubMed  Google Scholar 

  88. Van Gelder IC, Groenveld HF, Crijns HJ et al (2010) Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 362:1363–1373

    Article  PubMed  Google Scholar 

  89. van Walraven C, Oake N, Wells PS, Forster AJ (2007) Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromobembolic events in the elderly. Chest 131:1508–1515

    Article  PubMed  Google Scholar 

  90. Verheugt FW, Steinhubl SR, Hamon M et al (2011) Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. J Am Coll Cardiol Interv 4:191–197

    Google Scholar 

  91. Wang TJ, Larson MG, Levy D et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107:2920–2925

    Article  PubMed  Google Scholar 

  92. Wang TY, Xiao L, Alexander KP et al (2008) Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding. Circulation 118:2139–2145

    Article  PubMed  CAS  Google Scholar 

  93. Warkentin TE (2005) New approaches to the diagnosis of heparin-induced thrombocitopenia. Chest 127(2 Suppl):35S–45S

    Article  PubMed  CAS  Google Scholar 

  94. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG (2000) Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96:1703–1708

    PubMed  CAS  Google Scholar 

  95. Weitz JI, Eikelboom JW, Samama MM (2012) New antithrombotic drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 suppl):e120S–e151S

    Article  PubMed  CAS  Google Scholar 

  96. Wieloch M, Sjalander A, Frykman V, Rosenqvist M, Eriksson N, Svensson PJ (2011) Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA. Eur Heart J 32:2282–2289

    Article  PubMed  CAS  Google Scholar 

  97. Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001–2015

    Article  PubMed  CAS  Google Scholar 

  98. Xian Y, Liang L, Smith EE et al (2012) Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA 307:2600–2608

    Article  PubMed  CAS  Google Scholar 

  99. You JJ, Singer DE, Howard PA et al (2012) Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians. Evidence-based Clinical Practice Guidelines. Chest 141(2 suppl):e531S–e575S

    Article  PubMed  CAS  Google Scholar 

  100. Zacharski LR, Chow BK, Howes PS et al (2007) Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA 297:603–610

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The Fifth International Symposium of Thrombosis and Anticoagulation (ISTA V) was sponsored by unrestricted Grants from Bristol-Myers Squibb, Bayer Health Care, Daiichi Sankyo, Hospital do Coração Research Institute, and Hospital TotalCor. The symposium was organized by the Brazilian Clinical Research Institute, and the chairmen of the meeting thank Cecilia Jahnel, Marcia M. Barbosa, Maria da Consolacao V. Moreira, and Larissa Velano for all of their assistance in organizing the event.

Author information

Authors and Affiliations

  1. Duke Clinical Research Institute, Duke University Medical Center, P.O. Box 3850, 2400 Pratt Street, Room 0311, Terrace Level, Durham, NC, 27705, USA

    Renato D. Lopes, Richard C. Becker, L. Kristin Newby, Eric D. Peterson, Christopher B. Granger & Kenneth W. Mahaffey

  2. Paulista School of Medicine, Federal University of São Paulo, São Paulo, SP, Brazil

    Renato D. Lopes, Antonio C. Carvalho & Antonio C. Lopes

  3. Boston University, Boston, MA, USA

    Elaine M. Hylek

  4. Brigham and Women’s Hospital, Boston, MA, USA

    Robert Giugliano

  5. Hospital do Coração Research Institute, Heart Hospital, São Paulo, SP, Brazil

    Otavio Berwanger

  6. São Paulo University Medical School, São Paulo, SP, Brazil

    Roberto R. Giraldez

  7. Bahiana School of Medicine and Public Health, Salvador, BA, Brazil

    Gilson Soares Feitosa-Filho

  8. Ecocenter, Socor Hospital, Belo Horizonte, MG, Brazil

    Marcia M. Barbosa

  9. Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

    Maria da Consolacao V. Moreira

  10. Federal University of Health Science of Porto Alegre, Porto Alegre, RS, Brazil

    Renato A. K. Kalil

  11. João XXIII Hospital, Belo Horizonte, MG, Brazil

    Marildes Freitas

  12. Albert Einstein Hospital, São Paulo, SP, Brazil

    Joao Carlos de Campos Guerra

  13. Materdei Hospital, Belo Horizonte, MG, Brazil

    Marcio Vinicius Lins Barros

  14. Felício Rocho Hospital, Belo Horizonte, MG, Brazil

    Thiago da Rocha Rodrigues

  15. University of New Mexico Health Sciences Center, Albuquerque, NM, USA

    David A. Garcia

Authors
  1. Renato D. Lopes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard C. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Kristin Newby
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric D. Peterson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elaine M. Hylek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert Giugliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Christopher B. Granger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kenneth W. Mahaffey
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Antonio C. Carvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Otavio Berwanger
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Roberto R. Giraldez
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Gilson Soares Feitosa-Filho
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Marcia M. Barbosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Maria da Consolacao V. Moreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Renato A. K. Kalil
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Marildes Freitas
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Joao Carlos de Campos Guerra
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Marcio Vinicius Lins Barros
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Thiago da Rocha Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Antonio C. Lopes
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. David A. Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renato D. Lopes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lopes, R.D., Becker, R.C., Newby, L.K. et al. Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), october 18–19, 2012, Belo Horizonte, Minas Gerais, Brazil. J Thromb Thrombolysis 36, 115–130 (2013). https://doi.org/10.1007/s11239-013-0906-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-013-0906-z

Keywords

Search

Navigation